Terms: = Kidney tumors AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Treatment
66 results:
1. Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the treatment of Ovarian Cancer.
Wang JY; Gross M; Urban RR; Jorge S
Curr Treat Options Oncol; 2024 Mar; 25(3):313-329. PubMed ID: 38270801
[TBL] [Abstract] [Full Text] [Related]
2. Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab.
Shah NJ; Sura SD; Shinde R; Shi J; Singhal P; Perini RF; Motzer RJ
Urol Oncol; 2023 Nov; 41(11):459.e1-459.e8. PubMed ID: 37722984
[TBL] [Abstract] [Full Text] [Related]
3. Protective Effect of Platelet-Rich Plasma on Cisplatin-Induced Nephrotoxicity in Adult Male Albino Rats: Histological and Immunohistochemical Study.
Kelada MN; Elagawany A; El Sekily NM; El Mallah M; Abou Nazel MW
Biol Trace Elem Res; 2024 Mar; 202(3):1067-1083. PubMed ID: 37420147
[TBL] [Abstract] [Full Text] [Related]
4. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
[TBL] [Abstract] [Full Text] [Related]
5. L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and kidney/brain Axes.
Morid OF; Menze ET; Tadros MG; George MY
J Neuroimmune Pharmacol; 2023 Sep; 18(3):310-326. PubMed ID: 37140732
[TBL] [Abstract] [Full Text] [Related]
6. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation.
Yang W; Zhang Z; Li L; Zhang K; Xu Y; Xia M; Zhou J; Gong Y; Chen J; Gong K
Cell Death Dis; 2023 Mar; 14(3):212. PubMed ID: 36966163
[TBL] [Abstract] [Full Text] [Related]
7. treatment Strategies for Hereditary kidney Cancer: Current Recommendations and Updates.
Singh S; Chaurasia A; Gopal N; Malayeri A; Ball MW
Discov Med; 2022; 34(173):205-220. PubMed ID: 36602871
[TBL] [Abstract] [Full Text] [Related]
8. A Phase II Trial of Guadecitabine in Children and Adults with sdh-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Ligon JA; Sundby RT; Wedekind MF; Arnaldez FI; Del Rivero J; Wiener L; Srinivasan R; Spencer M; Carbonell A; Lei H; Shern J; Steinberg SM; Figg WD; Peer CJ; Zimmerman S; Moraly J; Xu X; Fox S; Chan K; Barbato MI; Andresson T; Taylor N; Pacak K; Killian JK; Dombi E; Linehan WM; Miettinen M; Piekarz R; Helman LJ; Meltzer P; Widemann B; Glod J
Clin Cancer Res; 2023 Jan; 29(2):341-348. PubMed ID: 36302175
[TBL] [Abstract] [Full Text] [Related]
9. Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy.
Ueno D; Vasquez JC; Sule A; Liang J; van Doorn J; Sundaram R; Friedman S; Caliliw R; Ohtake S; Bao X; Li J; Ye H; Boyd K; Huang RR; Dodson J; Boutros P; Bindra RS; Shuch B
Oncotarget; 2022; 13():1054-1067. PubMed ID: 36128328
[TBL] [Abstract] [Full Text] [Related]
10. The tumor and plasma cytokine profiles of renal cell carcinoma patients.
Lee MH; Laajala E; Kreutzman A; Järvinen P; Nísen H; Mirtti T; Hollmén M; Mustjoki S
Sci Rep; 2022 Aug; 12(1):13416. PubMed ID: 35927313
[TBL] [Abstract] [Full Text] [Related]
11. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.
Xu Z; Chen S; Liu R; Chen H; Xu B; Xu W; Chen M
Mol Cancer; 2022 Jul; 21(1):146. PubMed ID: 35840930
[TBL] [Abstract] [Full Text] [Related]
12. Adverse Urinary System Outcomes among Older Women with Endometrial Cancer.
Anderson C; Lund JL; Park J; Brewster W; Bae-Jump V; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1508. PubMed ID: 35775217
[TBL] [Abstract] [Full Text] [Related]
13. A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma.
Pan XQ; Huang W; Jin LW; Lin HZ; Xu XY
Dis Markers; 2022; 2022():8093837. PubMed ID: 35308143
[TBL] [Abstract] [Full Text] [Related]
14. Anticancer effect of locally applicable aptamer-conjugated gemcitabine-loaded atelocollagen patch in pancreatic cancer patient-derived xenograft models.
Hong SS; Lee S; Lee SH; Kim S; Kim D; Park H; Lee J; Lee JH; Kang CM
Cancer Sci; 2022 May; 113(5):1752-1762. PubMed ID: 35243724
[TBL] [Abstract] [Full Text] [Related]
15. Selective Toxicity Effect of Fatty Acids Omega-3, 6 and 9 Combination on Glioblastoma Neurons through their Mitochondria.
Seydi E; Sadeghi H; Ramezani M; Mehrpouya L; Pourahmad J
Drug Res (Stuttg); 2022 Feb; 72(2):94-99. PubMed ID: 34666393
[TBL] [Abstract] [Full Text] [Related]
16. [Eosinophilic, solid, and cystic renal cell carcinoma (ESC-RCC)].
Hartmann A; Agaimy A
Pathologe; 2021 Nov; 42(6):565-570. PubMed ID: 34550432
[TBL] [Abstract] [Full Text] [Related]
17. Hypopituitarism in patients with metastatic renal cell carcinoma treated with ipilimumab and nivolumab combination therapy.
Takagi T; Yoshida K; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Ishida H; Tanabe K
Jpn J Clin Oncol; 2021 Dec; 51(12):1744-1750. PubMed ID: 34487184
[TBL] [Abstract] [Full Text] [Related]
18. Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma.
Chen K; Zeng J; Sun Y; Ouyang W; Yu G; Zhou H; Zhang Y; Yao W; Xiao W; Hu J; Xing J; Xiao K; Wu L; Chen Z; Ye Z; Xu H
Cancer Commun (Lond); 2021 Apr; 41(4):316-332. PubMed ID: 33591636
[TBL] [Abstract] [Full Text] [Related]
19. Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma.
Gubbi S; Al-Jundi M; Del Rivero J; Jha A; Knue M; Zou J; Turkbey B; Carrasquillo JA; Lin E; Pacak K; Klubo-Gwiezdzinska J; Lin FI
Front Endocrinol (Lausanne); 2020; 11():587065. PubMed ID: 33551992
[TBL] [Abstract] [Full Text] [Related]
20. Risk Factors for Emergency Room and Hospital Care Among Patients With Solid tumors on Immune Checkpoint Inhibitor Therapy.
Parikh AB; Zhong X; Mellgard G; Qin Q; Patel VG; Wang B; Alerasool P; Garcia P; Leiter A; Gallagher EJ; Clinton S; Mortazavi A; Monk P; Folefac E; Yin M; Yang Y; Galsky M; Oh WK; Tsao CK
Am J Clin Oncol; 2021 Mar; 44(3):114-120. PubMed ID: 33417323
[TBL] [Abstract] [Full Text] [Related]
[Next]
